41
NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) “Relapsed/Refractory Multiple Myeloma”
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:April 14, 2022Completed
Refractory Multiple Myeloma: 1453 Clinical Trials, Page 5 of 146
Hide Studies Not Open or Pending
42
Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:December 8, 2022Completed
43
Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Condition(s):Relapsed and Refractory Multiple Myeloma (RRMM)Last Updated:February 8, 2023Active, not recruiting
44
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Relapsed Multiple MyelomaLast Updated:January 10, 2023Recruiting
45
Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:August 31, 2022Recruiting
46
A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:January 8, 2021Terminated
47
A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:December 9, 2022Active, not recruiting
48
A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:December 1, 2022Active, not recruiting
49
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused ABBV-383 of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:February 15, 2023Active, not recruiting
50
Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
Condition(s):Relapse/Refractory Multiple MyelomaLast Updated:November 18, 2019Completed